NVCR
Novocure Ltd
NASDAQ: NVCR · HEALTHCARE · MEDICAL DEVICES
$15.21
+27.49% today
Updated 2026-04-30
Market cap
$1.38B
P/E ratio
—
P/S ratio
2.11x
EPS (TTM)
$-1.22
Dividend yield
—
52W range
$10 – $20
Volume
1.6M
Novocure Ltd (NVCR) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-52.72M | $-74.24M | $-99.88M | $-107.59M | $-33.13M | $-1.86M | $26.62M | $99.15M | $82.76M | $30.79M | $-73.34M | $-26.37M | $-49.03M |
| Capital expenditures | $3.63M | $2.32M | $10.27M | $17.66M | $7.37M | $6.71M | $10.48M | $14.97M | $24.17M | $21.36M | $27.09M | $42.85M | $26.65M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $5.12M | $4.62M | $11.86M | $22.14M | $27.12M | $39.85M | $52.42M | $75.72M | $94.90M | $106.95M | $115.61M | $160.03M | $104.83M |
| Free cash flow | $-56.34M | $-76.56M | $-110.16M | $-125.26M | $-40.50M | $-8.58M | $16.14M | $84.18M | $58.59M | $9.43M | $-100.43M | $-69.22M | $-75.68M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $-19.64M | $-21.19M | $62.01M | $36.63M | $66.51M | $-36.38M | $-93.68M | — | — | — |